Skip to main content
VCbacked
Log inGet Started

ADmit Therapeutics

Barcelona, Spain

ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.

$6.1M raised
Jul 2023
Venture - Series Unknown
BiotechnologyHealth CareHealth DiagnosticsPharmaceutical

Top Investors

European Innovation CouncilAlzheimer's Drug Discovery FoundationGENESIS VenturesShip2BClave Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ADmit Therapeutics

How much funding has ADmit Therapeutics raised?
ADmit Therapeutics has raised $6.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
Who are ADmit Therapeutics's investors?
ADmit Therapeutics's investors include European Innovation Council, Alzheimer's Drug Discovery Foundation, GENESIS Ventures, Ship2B, Clave Capital.
Where is ADmit Therapeutics headquartered?
ADmit Therapeutics is headquartered in Barcelona, Spain.
What does ADmit Therapeutics do?
ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
What stage is ADmit Therapeutics at?
ADmit Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ADmit Therapeutics — Funding & Investors." VCBacked, July 19, 2023, https://www.vcbacked.co/company/admit-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). ADmit Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/admit-therapeutics
Wikipedia (cite web)
{{cite web |title=ADmit Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/admit-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong